Press release -

Genycell Biotech appointed as distributor in Spain & Portugal

Genycell Biotech was founded in 2001 as a supplier of products, services and technologies for basic and applied research within the areas of life science, biotechnology and biomedicine.

“We are delighted at the new partnership with Halo Genomics”, said Javier Martin, CEO of Genycell Biotech. “The Selector and HaloPlex PCR brands perfectly complement our existing portfolio of high quality products for life science research applications”.

“Genycell Biotech has the resources and in-country knowledge to provide detailed product expertise and excellent support to our growing customer base in Spain and Portugal.” said Maria Hjortsmark, Chief Business Officer of Halo Genomics.

Halo Genomics’ products were promoted at the 8th European Cytogenetics Conference (www.eca2011.org) in Porto, Portugal, earlier this month.

Learn more about Genycell at http://www.genycell.com/

Related links

Topics

  • Science, technology

Categories

  • library-free targeted resequencing
  • targeted resequencing
  • target enrichment
  • sample preparation
  • sample enrichment
  • resequencing
  • next generation sequencing (ngs).
  • biotechnology

Halo Genomics is a provider of innovative technology for sample preparation in next generation sequencing. Halo Genomics was founded by scientists from Uppsala University and Olink AB. Based in Uppsala, Sweden, the company's solutions are offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world.

Contacts

Olle Ericsson

Press contact CEO, Co-founder +46 18 495 31 20

Related media

Genycell Biotech appointed as distributor in Spain & Portugal
  • Genycell Biotech appointed as distributor in Spain & Portugal
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download

Related content

Halo Genomics signs Japanese distributor

UPPSALA, Sweden, June 16, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, announces the appointment of Nacalai Tesque, Inc. as its Japanese distributor.

Halo Genomics expands its European distributor network

UPPSALA, Sweden, May 27, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, today announced the appointment of Ozyme as its distributor in France.

Halo Genomics appoints South Korean distributor

UPPSALA, Sweden, March 24, 2011 – Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced the appointment of Molecular Diagnostics Korea Inc. (MDxK) as its Korean distributor.

Halo Genomics appoints Westburg B.V. as the distributor in Benelux

UPPSALA, Sweden, March 21, 2011 – Halo Genomics AB, a company providing products for next generation targeted sequencing, today announced that it has appointed Westburg B.V. as distributor in Belgium, the Netherlands and Luxemburg.

Biozym Scientific GmbH will distribute Halo Genomics’ products in Germany and Austria

UPPSALA, Sweden, March 7, 2011 – Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced its newest distribution partner, Biozym Scientific GmbH.

Integrated Sciences Pty Ltd. appointed as distributor in Australia and New Zealand

UPPSALA, Sweden, February 24, 2011 – Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced the appointment of Integrated Sciences Pty. as its distributor in Australia and New Zealand.

Cambio Ltd. appointed as distributor in United Kingdom

UPPSALA, Sweden, February 10, 2011 – Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced the appointment of Cambio Ltd as its distributor in the United Kingdom.